Company page

Pharvaris N.v.

Pharvaris N.V. is a public company traded under the ticker PHVS in the American market. With a market capitalization of approximately $2.15 billion, Pharvaris focuses on developing innovative treatments for patients with rare diseases. The company is dedicated to advancing its pipeline of therapies to address unmet medical needs.